Literature DB >> 32003871

Psychosocial burden of Hidradenitis Suppurativa patients' partners.

K Włodarek1, A Głowaczewska1, Ł Matusiak1, J C Szepietowski1.   

Abstract

BACKGROUND: Hidradenitis suppurativa is a debilitating disease related to a great psychosocial burden in affected patients and subsequently also people around them. Patients' partners as caregivers may indirectly experience wide range of devastating effects of the disease on their emotional and social life.
OBJECTIVE: The purpose of this study was to determine the QoL impairment in HS patients' partners and to identify its aspects that are affected the most. Correlation between QoL burden and disease severity, duration, sex, age and smoking was also assessed.
METHODS: A total of 50 HS sufferers were assessed according to disease severity and their partners' QoL was determined using the Family Dermatology Life Quality Index questionnaire.
RESULTS: The mean FDLQI for patients' partners was 8.7 ± 6.8 points, indicating generally a moderate effect of HS on their life. Quality of partners' life correlated significantly with disease severity but no correlation was found according to other factors.
CONCLUSION: Hidradenitis suppurativa is a highly psychologically devastating disease not only for patients but also for their partners. It occurred to diminish partners' QoL mostly by increasing daily expenditure but also other problems were often reported. Clinicians should be aware of these psychosocial implications, in order to provide optimal therapy of HS affected families by a multidisciplinary specialized management addressing both, patients and their cohabitants simultaneously.
© 2020 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2020        PMID: 32003871     DOI: 10.1111/jdv.16255

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

Review 1.  [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa].

Authors:  N Kirsten; V Frings; G D Nikolakis; D Presser; M Goebeler; C C Zouboulis; M Augustin
Journal:  Hautarzt       Date:  2021-07-05       Impact factor: 0.751

2.  Prevalence and Associated Factors of Alexithymia in Patients with Hidradenitis Suppurativa: A Cross-sectional Study.

Authors:  Amelia Głowaczewska; Jacek C Szepietowski; Łukasz Matusiak
Journal:  Acta Derm Venereol       Date:  2021-11-24       Impact factor: 3.875

3.  Sexuality in Patients with Hidradenitis Suppurativa: Beliefs, Behaviors and Needs.

Authors:  Carlos Cuenca-Barrales; Alejandro Molina-Leyva
Journal:  Int J Environ Res Public Health       Date:  2020-11-27       Impact factor: 3.390

Review 4.  Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature.

Authors:  R Shah; F M Ali; A Y Finlay; M S Salek
Journal:  Health Qual Life Outcomes       Date:  2021-08-05       Impact factor: 3.186

Review 5.  Quality of Life in Hidradenitis Suppurativa: An Update.

Authors:  Pavel V Chernyshov; Andrew Y Finlay; Lucia Tomas-Aragones; Francoise Poot; Francesca Sampogna; Servando E Marron; Sergey V Zemskov; Damiano Abeni; Thrasyvoulos Tzellos; Jacek C Szepietowski; Christos C Zouboulis
Journal:  Int J Environ Res Public Health       Date:  2021-06-06       Impact factor: 3.390

Review 6.  Gender differences in sexual health impairment in hidradenitis suppurativa: A systematic review.

Authors:  Danielle Yee; Erin K Collier; Swetha Atluri; Joanna Jaros; Vivian Y Shi; Jennifer L Hsiao
Journal:  Int J Womens Dermatol       Date:  2020-11-10

7.  Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?

Authors:  Piotr K Krajewski; Servando E Marrón; Lucía Tomas Aragones; Yolanda Gilaberte-Calzada; Jacek C Szepietowski
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.